Chronic Inhibition of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity Decreases Hypertension, Insulin Resistance, and Hypertriglyceridemia in Metabolic Syndrome
Figure 1
Absolute mean arterial pressure and heart rate in conscious, chronically instrumented obese and lean SHR-cp before and during chronic administration of vehicle or compound 11 (10 mg/kg/d).
